Status:
COMPLETED
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Lead Sponsor:
Zuyderland Medisch Centrum
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Rationale: Breast cancer patients are increasingly treated with neoadjuvant chemotherapy for various reasons. These women receive chemotherapy before any surgery is performed. Many of these tumors nee...
Detailed Description
Rationale: Breast cancer patients are increasingly treated with neoadjuvant chemotherapy for various reasons. These women receive chemotherapy before any surgery is performed. Many of these tumors nee...
Eligibility Criteria
Inclusion
- Included are non-pregnant women (\>18 years of age),
- Recently diagnosed with non-palpable invasive breast cancer or DCIS, requiring primary surgical treatment.
- Only women able to provide written informed consent will be considered for this study.
Exclusion
- \- Excluded are women not meeting the inclusion criteria.
Key Trial Info
Start Date :
September 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 10 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06049446
Start Date
September 8 2023
End Date
June 10 2024
Last Update
June 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuyderland Medical Center
Sittard, Limburg, Netherlands, 6162BG